Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3
- 4 May 2006
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 72 (1), 1-9
- https://doi.org/10.1016/j.antiviral.2006.03.016
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Targeting glycosylation as a therapeutic approachNature Reviews Drug Discovery, 2002
- The measles virus (MV) glycoproteins interact with cellular chaperones in the endoplasmic reticulum and MV infection upregulates chaperone expressionArchiv für die gesamte Virusforschung, 2001
- Antiviral Effect of N -Butyldeoxynojirimycin against Bovine Viral Diarrhea Virus Correlates with Misfolding of E2 Envelope Proteins and Impairment of Their Association into E1-E2 HeterodimersJournal of Virology, 2001
- Searching for Medicine's Sweet SpotScience, 2001
- Saving Lives With SugarScience, 2001
- α-Glucosidase Inhibitors Reduce Dengue Virus Production by Affecting the Initial Steps of Virion Morphogenesis in the Endoplasmic ReticulumJournal of Virology, 2000
- Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteinsVirus Research, 1994
- The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusionVirology, 1991
- Nucleotide Sequence of the Coding and Flanking Regions of the Human Parainfluenza Virus Type 3 Fusion Glycoprotein GeneJournal of General Virology, 1987